Carcinoma, Ductal - 30 Studies Found
| Not yet recruiting |
: Neo-adjuvant FOLF(IRIN)OX for Resectable Pancreatic Adenocarcinoma : Resectable Pancreatic Duct Adenocarcinoma : 2016-11-03 :
|
| Completed |
: Evaluation of Percutaneous Treatment by Cryoablation of Unifocal Invasive Breast Carcinoma in Menopausal Women With Indication of Lumpectomy :
: 2015-10-12 : Device: Cryoablation Other Name: Cryotherapy |
| Completed |
: Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial For Low Risk DCIS :
: 2016-09-19 :
|
| Completed |
: Clinical Outcome of Chemotherapy in Surgical Patients With Infiltrating Ductal Carcinoma of Breast : Breast Cancer : 2016-08-25 :
|
| Terminated |
: Vitamin D3 (Vit D3) Supplementation and T Cell Immunomodulation in Patients With Newly Diagnosed Operative Invasive Ductal Breast Carcinoma : Newly Diagnosed Operative Invasive Ductal Breast Carcinoma Stage I-II : 2013-02-06 : Dietary Supplement: Vitamin D Subjects will be assigned to a dosage level between 600IU daily and 10,000 |
| Completed |
: Lapatinib Ditosylate in Treating Patients With Ductal Breast Carcinoma In Situ :
|
| Completed |
: Neoadjuvant Therapy in TRIPle Negative Breast Cancer With antiPDL1 : Invasive Ductal Breast Carcinoma : 2015-11-03 :
|
| Completed |
: Lumpectomy Followed By Intraoperative Electron Radiation Therapy (IOERT) :
: Radiation: Intraoperative Electron Radiotherapy Intraoperative Electron Radiotherapy (IOERT) is delivere |
| Recruiting |
: Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancer : Ductal Breast Carcinoma In Situ : 2015-12-18 :
|
| Completed |
: G1T38, a CDK 4/6 Inhibitor, in Combination With Fulvestrant in Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer :
|